We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FVCB:NASDAQFVCBankcorp, Inc. Analysis

Data as of 2026-04-05 - not real-time

$15.21

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

FVCBankcorp is trading at $15.21, comfortably above its 20‑day SMA of $14.91 but just shy of the 50‑day SMA of $15.27, indicating short‑term strength while the 200‑day SMA of $13.56 confirms a longer‑term uptrend. The stock’s PE of 12.6 is well below the industry average of 16.6 and the DCF‑derived fair value of $24.88 suggests roughly 16% upside, classifying the equity as undervalued. Robust operating margins (45% operating, 34% profit) and a 10% revenue growth rate underpin a solid earnings foundation, complemented by a low payout ratio (≈10%) and a 1.58% dividend yield, which appear sustainable given the $129 M cash balance and minimal debt. Technical signals are bullish – the MACD histogram is positive and volume is increasing – while the Fear & Greed Index at 78.8 signals extreme market optimism. Recent corporate actions, including the $25 M senior notes completion, an extended share‑repurchase program, and a quarterly dividend declaration, reinforce confidence, though a modest insider sell‑off adds a neutral note.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram with increasing volume
  • Price positioned between support $14.31 and resistance $15.54
  • Neutral trend direction and modest beta of 0.73

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~16% and PE well below industry average
  • Strong operating margins and 10% revenue growth
  • Sustainable dividend and low debt relative to cash

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervalued valuation with significant fair‑value gap
  • Solid balance sheet (high cash, minimal debt) and low beta
  • Ongoing share‑repurchase program and consistent dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth10.20%
Profit Margin33.51%
P/E Ratio12.6
ROE9.02%
ROA0.98%
P/B Ratio1.1
Op. Cash Flow$23.9M
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI54.5
Support$14.31
Resistance$15.54
MA 20$14.91
MA 50$15.27
MA 200$13.56
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$24.88
Target Price$17.63
Upside/Downside15.88%
GradeUndervalued
TypeBlend
Dividend Yield1.58%

Risk Assessment

Beta0.74
Volatility19.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.